N&N hospital patients are tested for an antibiotic resistant superbug
- Credit: Evening News © 2009
Patients at the Norfolk and Norwich University Hospital have been tested for an antibiotic-resistant superbug, it has emerged.
Six people were screened for carbapenemase-producing enterobacteriaceae (CPE) – a bacteria capable of resisting the most powerful antibiotics – after coming into contact with a patient who had recently been discharged from a foreign hospital.
Three of the six tested negative and the results of the remaining patients, who are now all at home, are due to emerge soon.
Dr Ngozi Elumogo, director of infection prevention and control at the N&N, said the hospital is confident all appropriate measures were taken and there is no public health risk.
CPE are bacteria that live in the gut and are normally harmless.
You may also want to watch:
But if they get into other parts of the body, such as the bladder or bloodstream, they can cause an infection. There are usually no symptoms until an infection appears.
Carbapenems are strong antibiotics similar to penicillin and are used by doctors as a 'last resort' to treat some infections when other antibiotics have failed.
- 1 Famous Norwich firm locked in legal battle with Red Bull
- 2 'I couldn't believe my eyes' - snorkeller finds 125-year-old shipwreck
- 3 End of an era as cafe owner hangs up apron after 26 years
- 4 Location revealed for new major music festival with '90s flavour'
- 5 Huge village home with indoor swimming pool for sale for £1.2m
- 6 Former teacher who abused young boys handed 25-year sentence
- 7 Do you recognise this man?
- 8 Norfolk beach ranked among world's top tourist attractions
- 9 Huge Christmas market returning to Norfolk Showground for 2021
- 10 Bus services to be cancelled and changed amid driver shortage
Dr Elumogo said: 'A patient who was recently discharged from a hospital overseas and then admitted to the Norfolk and Norwich University Hospital in early September 2015 has tested positive for CPE in samples taken on admission to NNUH.
'There is no requirement to screen family contacts as this organism does not usually cause a problem in healthy people.'
A recent study found that operations could become 'virtually impossible' without urgent action to tackle the threat posed by antibiotic resistance.
Scientists at the Center for Disease Dynamics, Economics & Policy in Washington DC predict that in the US alone, even a 10pc reduction in the effectiveness of treatments to prevent surgical infections would result in 2,100 more deaths each year.
They estimate that if the drugs lost 30pc of their power to protect against bugs, it would lead to 120,000 more infections and 6,300 more patients dying. In the worst scenario, a 70pc drop in efficacy was expected to add 5,000 lost lives to the US death toll.
Last year Public Health England (PHE) launched a toolkit for hospitals to help them control antibiotic-resistant bacterial infections caused by CPE.
Do you have a health story? Email email@example.com.